Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Stimuli-responsive Nanoparticle

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · JOURNAL ARTICLE

Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision.

International Journal of Pharmaceutics: X

This is a narrative review proposing conceptual frameworks for nanoparticle-mediated CRISPR delivery; it does not report primary experimental data, efficacy outcomes, or comparative evidence.

Hypothesis-GeneratingStimuli-responsive Nanoparticle Crispr/cas9 Sabreena Safuan

Study details

DesignNarrative review

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support